ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,066.00
-0.07%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,970.95
-0.16%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. AMEX
  6. NanoViricides Inc (NNVC)

  7. NanoViricides Inc (NNVC) 뉴스

NNVC

NanoViricides (NNVC)

NanoViricides Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:NNVC
일자시간출처헤드라인심볼기업
2024/05/0223:07InvestorsHub NewsWireNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected SoonAMEX:NNVCNanoViricides Inc
2024/02/1706:53Edgar (US Regulatory)Form 8-K - Current reportAMEX:NNVCNanoViricides Inc
2024/02/1506:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NNVCNanoViricides Inc
2024/01/2006:44Edgar (US Regulatory)Form 8-K - Current reportAMEX:NNVCNanoViricides Inc
2023/12/0506:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:NNVCNanoViricides Inc
2023/10/1405:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:NNVCNanoViricides Inc
2023/09/2905:44Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NNVCNanoViricides Inc
2023/09/0205:46Edgar (US Regulatory)Form 8-K - Current reportAMEX:NNVCNanoViricides Inc
2023/07/0700:16InvestorsHub NewsWireClinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical NeedsAMEX:NNVCNanoViricides Inc
2023/05/2605:34Edgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
2023/05/0906:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:NNVCNanoViricides Inc
2023/05/0419:45GlobeNewswire Inc.NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York CityAMEX:NNVCNanoViricides Inc
2023/02/1507:24Edgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
2023/02/1407:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
2022/12/2320:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:NNVCNanoViricides Inc
2022/11/1606:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
2022/11/0505:33Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:NNVCNanoViricides Inc
2022/10/1406:13Edgar (US Regulatory)Annual Report (10-k)AMEX:NNVCNanoViricides Inc
2022/09/3001:20Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:NNVCNanoViricides Inc
2022/08/1107:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:NNVCNanoViricides Inc
2022/05/1705:55Edgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
2021/11/1606:55Edgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
2021/11/1521:09InvestorsHub NewsWireNanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2AMEX:NNVCNanoViricides Inc
2021/10/1219:16Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
2021/10/1119:49InvestorsHub NewsWireNanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus ActivityAMEX:NNVCNanoViricides Inc
2021/10/0519:45PR Newswire (US)NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap ConferenceAMEX:NNVCNanoViricides Inc
2021/10/0519:45PR Newswire (US)NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap ConferenceAMEX:NNVCNanoViricides Inc
2021/09/2905:32Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:NNVCNanoViricides Inc
2021/09/2219:48InvestorsHub NewsWireSignificantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral DrugAMEX:NNVCNanoViricides Inc
2021/09/2219:45PR Newswire (US)Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral DrugAMEX:NNVCNanoViricides Inc
 검색 관련기사 보기:AMEX:NNVC

최근 히스토리

LSE
BN44
Citi Fun 24
LSE
FS05
Citi Fun 27
COIN
CRMCUST
CHREMACOIN
COIN
ZXCETH
0xcert Protocol Token
COIN
LRAUSD
GATE
GNTETH
MRTX
PRIXBTC
Privatix
AMEX
SLX
VanEck Steel ETF
NASDAQ
PGAHX
PGIM QMAW Systematic Abs...
NASDAQ
FNPUAX
Strategic International ...
TG
FE0
Stallion Uranium
BIT
UB4H0M
Unicredit Bank
BINA
SSVETH
SSV Token
BIT
S25031
SG ISSUER
LSE
56QU
Gran 04 3 1b
LSE
SOF
Somerfield
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유